Product Images Imatinib Mesylate

This is a figure caption, therefore it is not possible to provide a useful description based purely on it.*

The text contains a figure related to a study on recurrence-free survival. The graphs show the probability of recurrence-free survival in months along with hazard ratio and probability ratio. However, the text is not clear enough for a detailed description.*

This is a figure showing study 2's ITT population's overall survival. The x-axis represents survival time in months, and the y-axis represents the number of events. The graph displays two lines, one for Imatinib at 12 months (795 observations) and another for Imatinib at 36 months (188 observations). There were 111 censored observations. The hazard ratio is 0.45 with a 95% confidence interval of 0.22 to 0.89. No further information about the study, events, and observations is provided.*

This is a prescription drug called Imatinib Mesylate. It comes in the form of film-coated tablets and is available in a pack of 30. Each tablet contains 100 mg of Imatinib Mesylate. The usual dosage and other important details are given in the package insert. It needs to be stored between 20°C to 25°C and protected from moisture. This drug is distributed by Amneal Pharmaceuticals LLC from Bridgewater, NJ.*

This is a description of a medication with the NDC code 65162-795-03. The medication is Imatinib Mesylate and it is in tablet form with a film coating. Each tablet contains 400 mg of imatinib free base. The usual dosage is not provided in the text, and the user should refer to the package insert. The medication should be stored between 20" to 25°C (68" to 77°F), with excursions allowed between 15° to 30°C (59" to 86°F). The medication should be protected from moisture, and it should be stored in a tight container as defined in the USP. This medication is distributed by Amneal Pharmaceuticals LLC, located in Bridgewater, NJ.*